Navigation Links
New and Unique Tool Eases the Process of Finding Article Reviewers
Date:9/6/2010

New and Unique Tool Eases the Process of Finding Article Reviewers -- AMSTERDAM, September 6, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Publishing & Information Services, Biotechnology, Medical Equipment, New Products & Services Click to view news release full screen  

New and Unique Tool Eases the Process of Finding Article Reviewers

 

AMSTERDAM, September 6, 2010 /PRNewswire-FirstCall/ --

- Elsevier Continues to Support the Peer Review Process by Developing a Tool to Help Journal Editors Find Reviewers

Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, announced today the launch of a new and unique tool to help editors find reviewers ( http://support.elsevier.com/app/answers/detail/a_id/710), which addresses the number one pain point for journal editors. Developed in close consultation with journal editors, this tool which is accessible from EES - Elsevier's Editorial and peer review system - suggests a list of potential reviewers.

Accessible from within EES, editors can search by topic or by name and check for any conflicts of interest. The search is based on the Scopus algorithm for ranking published articles; potential reviewers are listed based on the number of their relevant articles, drawn from over 13,000 journals in Scopus (http://www.scopus.com/home.url) . The results of the search will suggest potential reviewers and provide editors with information to help determine their suitability based on their published work, citations, h-index and conflicts of interest checks with the manuscript under review - previous co-authorship or affiliation to the same institute.

"We hear from editors that the task of finding suitable reviewers can be challenging, and due to the increase in submitted manuscripts, that it is becoming more of an issue. We listen to our editors, and this is just one of the initiatives we have implemented to further support them and the peer review process. This tool will not only help editors to expand their network of reviewers and thus improve and speed up the peer review process, but also will increase reviewers' satisfaction by inviting them to review relevant research," said Martin Tanke, MD S&T Journal Publishing, Elsevier.

"Participating in the usability testing to develop this tool with Elsevier allowed me to give input on the often time-consuming task of searching for reviewers. It will be very helpful to editors in finding suitable reviewers, but also to reviewers who will be asked to review manuscripts specifically relevant to them," remarked Maja Zecevic, North American Senior Editor, The Lancet.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com ), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact John Lardee +31-20-4853416 J.Lardee@elsevier.com
'/>"/>

SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Interventional Spine®, Inc. Announces Continued Success With Its Unique PERPOS® Percutaneous Cervical System
2. arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform
3. New Georgia Advanced Surgery Center Provides Women Many Unique Benefits
4. Patent Awarded to the Design of TechniScans Unique 3-D Breast Imaging System
5. Enigma Diagnostics Showcases Its Unique Fully Automated rtPCR Based ML (Mini-Laboratory) Instrument For Point-of-Care Testing at MEDICA 2009 In Dusseldorf, Germany
6. A Unique Endoluminal Approach for the Treatment of Morbid Obesity Selected for Presentation at the 2009 American College of Surgeons Clinical Congress
7. National Long Term Care Leaders Praise Senator Snowes Recognition of Nursing Homes Unique Funding Challenges in Caring for Nations Seniors
8. Weekly Digests Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 Swine Flu Outbreak
9. Transparent Inc. to Introduce Cell-able, a Unique Human Hepatocyte Array, to U.S. Market at ISSX Meeting
10. National Cancer Institute Research Identifies Unique Mechanism of Brostallicins Anti-Tumor Effectiveness
11. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology:
(Date:4/29/2017)... Louisiana (PRWEB) , ... April 29, 2017 , ... ... Brookshire’s Grocery Company to the list of fine retailers selling biodegradable, hanging flushable ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more ...
(Date:4/28/2017)... ... 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses the case ... help of a weight loss surgery. The woman, declaring “I will not hate my body ... following her dramatic weight loss. Dr. Feiz & Associates notes that, while it often refers ...
(Date:4/28/2017)... , ... April 28, 2017 , ... It's not always ... a number of illnesses that are unclear as to whether or not they are ... Bronchitis is one of these illnesses. So, FindaTopDoc took a look into the matter. ...
(Date:4/28/2017)... ... 2017 , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced ... its outlook as “stable.” At the same time, the ratings agency cautioned that the ... dip below “capital adequacy” thresholds required for its strong rating. , “Horizon is committed ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... , http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” ... Water, Global Climate Change and Your Health on Voice America sponsored by Nature’s ...
Breaking Medicine News(10 mins):